Catalog |
name |
Description |
price |
R-R-0637 |
Human IgE Pentapeptide HEPP |
Human IgE Pentapeptide HEPP/CAS 62087-72-3 from ruixi. Has been shown to inhibit cutaneous and systemic IgE mediated allergic reactions in humans. |
price> |
R-R-0645 |
Epidermal Mitosis Inhibiting Pentapeptide |
Epidermal Mitosis Inhibiting Pentapeptide/CAS 106678-69-7 from ruixi. After intraperitoneal injection, this pentapeptide reversibly inhibits epidermal mitosis. |
price> |
R-R-0651 |
Myosin Kinase Inhibiting Peptide |
Myosin kinase inhibiting peptide refers to a peptide that is specifically designed to inhibit myosin light chain kinase (MLCK), an enzyme involved in the regulation of smooth muscle contraction. By inhibiting the activity of MLCK, this peptide can potentially modulate smooth muscle function and lead to physiological effects such as vasodilation or inhibition of smooth muscle contraction. |
price> |
R-R-0662 |
Cbz-Phe-(Alloc)Lys-PAB-PNP |
Cbz-Phe-(Alloc)Lys-PAB-PNP is an antibody that recognizes the N-terminus of the alpha subunit of the nicotinic acetylcholine receptor. The antibody can be used to determine if a ligand binds to a receptor and is an activator or inhibitor. The antibody is also suitable for use in pharmacology/pharmacokinetics studies and as a research tool. |
price> |
R-R-0697 |
(FMOC-GLU70,ALA71,72,LYS74)-C3A (70-77) |
(FMOC-GLU70,ALA71,72,LYS74)-C3A (70-77)/CAS:145082-23-1 from ruixi. This peptide is a potent inhibitor of C3a activity. |
price> |
R-R-0718 |
Biotin-Obestatin (human) |
Biotin-Obestatin (human) refers to the peptide obestatin, which has been modified with the addition of biotin. Obestatin is a relatively newly discovered peptide derived from the same precursor as ghrelin and has been implicated in appetite regulation, gastrointestinal motility, and energy homeostasis. |
price> |
R-R-0719 |
Biotin-Obestatin (rat) |
Biotin-Obestatin (rat) refers to the peptide obestatin, originally derived from rats, which has been modified with the addition of biotin. Obestatin is a peptide that has been implicated in appetite regulation, gastrointestinal motility, and energy homeostasis in rodents. |
price> |
R-R-0745 |
[D-Phe12]-Bombesin |
[D-Phe12]-Bombesin/CAS:108437-87-2 is a selective bombesin receptor antagonist. Bombesin receptor antagonist; inhibits bombesin-induced amylase release in guinea pig pancreas (IC50 = 4 mM). Centrally active in vivo. |
price> |
R-R-0751 |
[D-Pro2,D-Phe7,D-Trp9]-Substance P |
[D-Pro2,D-Phe7,D-Trp9] Substance P/CAS:77275-70-8 is a Substance P (HY-P0201) analogue. [D-Pro2,D-Phe7,D-Trp9] Substance P is an inhibitor of Substance P. [D-Pro2,D-Phe7,D-Trp9] Substance P contracts guinea-pig ileum (GPI) indirectly. |
price> |
R-R-0755 |
[D-Phe7, D-Trp10]-Somatostatin 14 (7-14) |
[D-Phe7, D-Trp10]-Somatostatin 14 (7-14) is a modified version of the natural peptide somatostatin-14 with alterations at positions 7 and 10. In this modified peptide, the seventh amino acid phenylalanine and the tenth amino acid tryptophan have been replaced by their D-enantiomer forms (D-Phe and D-Trp, respectively). Somatostatin-14 is a potent inhibitor of various physiological processes including the release of growth hormone, insulin, and glucagon. |
price> |